Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Response to "Do different treatment strategies of galcanezumab have similar effect on migraine?"

Goadsby PJ, Terwindt GM, Ruff DD, Ford JH, Tockhorn-Heidenreich A, Stauffer VL, Govindan S, Aurora SK.

Eur J Neurol. 2020 Feb 12. doi: 10.1111/ene.14168. [Epub ahead of print]

PMID:
32052515
2.

Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients.

Gravesteijn G, Dauwerse JG, Overzier M, Brouwer G, Hegeman I, Mulder AA, Baas F, Kruit MC, Terwindt GM, van Duinen SG, Jost CR, Aartsma-Rus A, Lesnik Oberstein SAJ, Rutten JW.

Hum Mol Genet. 2020 Jan 21. pii: ddz285. doi: 10.1093/hmg/ddz285. [Epub ahead of print]

PMID:
31960911
3.

Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.

Bangs ME, Kudrow D, Wang S, Oakes TM, Terwindt GM, Magis D, Yunes-Medina L, Stauffer VL.

BMC Neurol. 2020 Jan 17;20(1):25. doi: 10.1186/s12883-020-1609-7.

4.

Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas.

Liu J, Lahousse L, Nivard MG, Bot M, Chen L, van Klinken JB, Thesing CS, Beekman M, van den Akker EB, Slieker RC, Waterham E, van der Kallen CJH, de Boer I, Li-Gao R, Vojinovic D, Amin N, Radjabzadeh D, Kraaij R, Alferink LJM, Murad SD, Uitterlinden AG, Willemsen G, Pool R, Milaneschi Y, van Heemst D, Suchiman HED, Rutters F, Elders PJM, Beulens JWJ, van der Heijden AAWA, van Greevenbroek MMJ, Arts ICW, Onderwater GLJ, van den Maagdenberg AMJM, Mook-Kanamori DO, Hankemeier T, Terwindt GM, Stehouwer CDA, Geleijnse JM, 't Hart LM, Slagboom PE, van Dijk KW, Zhernakova A, Fu J, Penninx BWJH, Boomsma DI, Demirkan A, Stricker BHC, van Duijn CM.

Nat Med. 2020 Jan;26(1):110-117. doi: 10.1038/s41591-019-0722-x. Epub 2020 Jan 13.

PMID:
31932804
5.

Emerging treatments for headache: advances in 2019.

Terwindt GM.

Lancet Neurol. 2020 Jan;19(1):7-8. doi: 10.1016/S1474-4422(19)30439-9. No abstract available.

PMID:
31839249
6.

Increased Mortality and Vascular Phenotype in a Knock-In Mouse Model of Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.

Mulder IA, Rubio-Beltran E, Ibrahimi K, Dzyubachyk O, Khmelinskii A, Hoehn M, Terwindt GM, Wermer MJH, MaassenVanDenBrink A, van den Maagdenberg AMJM.

Stroke. 2020 Jan;51(1):300-307. doi: 10.1161/STROKEAHA.119.025176. Epub 2019 Dec 6.

PMID:
31805844
7.

Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine.

Pijpers JA, Ferrari MD, Terwindt GM.

Brain. 2020 Jan 1;143(1):e6. doi: 10.1093/brain/awz368. No abstract available.

PMID:
31782777
8.

Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials.

Ruff DD, Ford JH, Tockhorn-Heidenreich A, Stauffer VL, Govindan S, Aurora SK, Terwindt GM, Goadsby PJ.

Eur J Neurol. 2019 Nov 6. doi: 10.1111/ene.14114. [Epub ahead of print]

PMID:
31692188
9.

Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls.

Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ, Pool R, Thesing CS, Vijfhuizen LS, Vogelzangs N, Arts ICW, Demirkan A, van Duijn C, van Greevenbroek M, van der Kallen CJH, Köhler S, Ligthart L, van den Maagdenberg AMJM, Mook-Kanamori DO, de Mutsert R, Tiemeier H, Schram MT, Stehouwer CDA, Terwindt GM, Willems van Dijk K, Fu J, Zhernakova A, Beekman M, Slagboom PE, Boomsma DI, Penninx BWJH; BBMRI-NL Metabolomics Consortium.

Biol Psychiatry. 2020 Mar 1;87(5):409-418. doi: 10.1016/j.biopsych.2019.08.016. Epub 2019 Aug 29.

PMID:
31635762
10.

Microstructural white matter changes preceding white matter hyperintensities in migraine.

Arkink EB, Palm-Meinders IH, Koppen H, Milles J, van Lew B, Launer LJ, Hofman PAM, Terwindt GM, van Buchem MA, Ferrari MD, Kruit MC.

Neurology. 2019 Aug 13;93(7):e688-e694. doi: 10.1212/WNL.0000000000007940. Epub 2019 Jul 11.

PMID:
31296653
11.

Treatment effects and comorbid diseases in 58 patients with visual snow.

van Dongen RM, Waaijer LC, Onderwater GLJ, Ferrari MD, Terwindt GM.

Neurology. 2019 Jul 23;93(4):e398-e403. doi: 10.1212/WNL.0000000000007825. Epub 2019 Jun 18.

12.

MRI evaluation of the relationship between carotid artery endothelial shear stress and brain white matter lesions in migraine.

Hoogeveen ES, Arkink EB, van der Grond J, van Buchem MA, Ferrari MD, Terwindt GM, Kruit MC; PROSPER Study Group.

J Cereb Blood Flow Metab. 2019 Jun 18:271678X19857810. doi: 10.1177/0271678X19857810. [Epub ahead of print]

PMID:
31213163
13.

Stroke progression and clinical outcome in ischemic stroke patients with a history of migraine.

Mulder IA, Holswilder G, van Walderveen MA, van der Schaaf IC, Bennink E, Horsch AD, Kappelle LJ, Velthuis BK, Dankbaar JW, Terwindt GM, Schonewille WJ, Visser MC, Ferrari MD, Algra A, Wermer MJ; DUST investigators.

Int J Stroke. 2019 Dec;14(9):946-955. doi: 10.1177/1747493019851288. Epub 2019 May 27.

PMID:
31132969
14.

Letter to the Editor.

Boer I, Maagdenberg AMJMVD, Terwindt GM.

Rev Invest Clin. 2019;71(2):141-142. doi: 10.24875/RIC.19002979. No abstract available.

PMID:
31066373
15.

Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.

Pijpers JA, Kies DA, Louter MA, van Zwet EW, Ferrari MD, Terwindt GM.

Brain. 2019 May 1;142(5):1203-1214. doi: 10.1093/brain/awz052.

16.

Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine.

Onderwater GLJ, Ligthart L, Bot M, Demirkan A, Fu J, van der Kallen CJH, Vijfhuizen LS, Pool R, Liu J, Vanmolkot FHM, Beekman M, Wen KX, Amin N, Thesing CS, Pijpers JA, Kies DA, Zielman R, de Boer I, van Greevenbroek MMJ, Arts ICW, Milaneschi Y, Schram MT, Dagnelie PC, Franke L, Ikram MA, Ferrari MD, Goeman JJ, Slagboom PE, Wijmenga C, Stehouwer CDA, Boomsma DI, van Duijn CM, Penninx BW, 't Hoen PAC, Terwindt GM, van den Maagdenberg AMJM; BBMRI Metabolomics Consortium.

Neurology. 2019 Apr 16;92(16):e1899-e1911. doi: 10.1212/WNL.0000000000007313. Epub 2019 Apr 3.

17.

Advance in genetics of migraine.

de Boer I, van den Maagdenberg AMJM, Terwindt GM.

Curr Opin Neurol. 2019 Jun;32(3):413-421. doi: 10.1097/WCO.0000000000000687.

18.

TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features.

de Boer I, van den Maagdenberg AMJM, Terwindt GM.

Am J Kidney Dis. 2019 Jun;73(6):893. doi: 10.1053/j.ajkd.2018.12.041. Epub 2019 Mar 4. No abstract available.

PMID:
30846258
19.

Circle of Willis variations in migraine patients with ischemic stroke.

Hamming AM, van Walderveen MAA, Mulder IA, van der Schaaf IC, Kappelle LJ, Velthuis BK, Ferrari MD, Terwindt GM, Visser MC, Schonewille W, Algra A, Wermer MJH; Dutch acute Stroke Study (DUST) investigators.

Brain Behav. 2019 Mar;9(3):e01223. doi: 10.1002/brb3.1223. Epub 2019 Feb 16.

20.

Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.

Schouten TM, de Vos F, van Rooden S, Bouts MJRJ, van Opstal AM, Feis RA, Terwindt GM, Wermer MJH, van Buchem MA, Greenberg SM, de Rooij M, Rombouts SARB, van der Grond J.

J Am Heart Assoc. 2019 Feb 5;8(3):e011288. doi: 10.1161/JAHA.118.011288.

21.

Generation of 3 human induced pluripotent stem cell lines LUMCi005-A, B and C from a Hereditary Cerebral Hemorrhage with Amyloidosis-Dutch type patient.

Daoutsali E, Buijsen RAM, van de Pas S, Jong A', Mikkers H, Brands T, Eussen B, de Klein A, van der Graaf LM, Pepers BA, Freund C, Terwindt GM, Orlova VV, van Roon-Mom WMC.

Stem Cell Res. 2019 Jan;34:101359. doi: 10.1016/j.scr.2018.101359. Epub 2018 Dec 14.

22.

Alcoholic beverages as trigger factor and the effect on alcohol consumption behavior in patients with migraine.

Onderwater GLJ, van Oosterhout WPJ, Schoonman GG, Ferrari MD, Terwindt GM.

Eur J Neurol. 2019 Apr;26(4):588-595. doi: 10.1111/ene.13861. Epub 2018 Dec 18.

PMID:
30565341
23.

Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease.

Pelzer N, Hoogeveen ES, Haan J, Bunnik R, Poot CC, van Zwet EW, Inderson A, Fogteloo AJ, Reinders MEJ, Middelkoop HAM, Kruit MC, van den Maagdenberg AMJM, Ferrari MD, Terwindt GM.

J Intern Med. 2019 Mar;285(3):317-332. doi: 10.1111/joim.12848. Epub 2018 Nov 8.

PMID:
30411414
24.

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).

Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Gantenbein AR, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Paemeleire K, Sandset PM, Terwindt GM, Vetvik KG, Martelletti P; European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH).

J Headache Pain. 2018 Aug 31;19(1):76. doi: 10.1186/s10194-018-0896-5. Review.

25.

RVCL-S and CADASIL display distinct impaired vascular function.

de Boer I, Stam AH, Buntinx L, Zielman R, van der Steen I, van den Maagdenberg AMJM, de Koning EJP, Ferrari MD, de Hoon JN, Terwindt GM.

Neurology. 2018 Sep 4;91(10):e956-e963. doi: 10.1212/WNL.0000000000006119. Epub 2018 Aug 3.

PMID:
30076273
26.

Molecular genetic overlap between migraine and major depressive disorder.

Yang Y, Zhao H, Boomsma DI, Ligthart L, Belin AC, Smith GD, Esko T, Freilinger TM, Hansen TF, Ikram MA, Kallela M, Kubisch C, Paraskevi C, Strachan DP, Wessman M; International Headache Genetics Consortium, van den Maagdenberg AMJM, Terwindt GM, Nyholt DR.

Eur J Hum Genet. 2018 Aug;26(8):1202-1216. doi: 10.1038/s41431-018-0150-2. Epub 2018 Jul 11.

27.

Female sex hormones in men with migraine.

van Oosterhout WPJ, Schoonman GG, van Zwet EW, Dekkers OM, Terwindt GM, MaassenVanDenBrink A, Ferrari MD.

Neurology. 2018 Jul 24;91(4):e374-e381. doi: 10.1212/WNL.0000000000005855. Epub 2018 Jun 27.

PMID:
29950439
28.

Analysis of shared heritability in common disorders of the brain.

Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, Malik R, Patsopoulos NA, Ripke S, Wei Z, Yu D, Lee PH, Turley P, Grenier-Boley B, Chouraki V, Kamatani Y, Berr C, Letenneur L, Hannequin D, Amouyel P, Boland A, Deleuze JF, Duron E, Vardarajan BN, Reitz C, Goate AM, Huentelman MJ, Kamboh MI, Larson EB, Rogaeva E, St George-Hyslop P, Hakonarson H, Kukull WA, Farrer LA, Barnes LL, Beach TG, Demirci FY, Head E, Hulette CM, Jicha GA, Kauwe JSK, Kaye JA, Leverenz JB, Levey AI, Lieberman AP, Pankratz VS, Poon WW, Quinn JF, Saykin AJ, Schneider LS, Smith AG, Sonnen JA, Stern RA, Van Deerlin VM, Van Eldik LJ, Harold D, Russo G, Rubinsztein DC, Bayer A, Tsolaki M, Proitsi P, Fox NC, Hampel H, Owen MJ, Mead S, Passmore P, Morgan K, Nöthen MM, Rossor M, Lupton MK, Hoffmann P, Kornhuber J, Lawlor B, McQuillin A, Al-Chalabi A, Bis JC, Ruiz A, Boada M, Seshadri S, Beiser A, Rice K, van der Lee SJ, De Jager PL, Geschwind DH, Riemenschneider M, Riedel-Heller S, Rotter JI, Ransmayr G, Hyman BT, Cruchaga C, Alegret M, Winsvold B, Palta P, Farh KH, Cuenca-Leon E, Furlotte N, Kurth T, Ligthart L, Terwindt GM, Freilinger T, Ran C, Gordon SD, Borck G, Adams HHH, Lehtimäki T, Wedenoja J, Buring JE, Schürks M, Hrafnsdottir M, Hottenga JJ, Penninx B, Artto V, Kaunisto M, Vepsäläinen S, Martin NG, Montgomery GW, Kurki MI, Hämäläinen E, Huang H, Huang J, Sandor C, Webber C, Muller-Myhsok B, Schreiber S, Salomaa V, Loehrer E, Göbel H, Macaya A, Pozo-Rosich P, Hansen T, Werge T, Kaprio J, Metspalu A, Kubisch C, Ferrari MD, Belin AC, van den Maagdenberg AMJM, Zwart JA, Boomsma D, Eriksson N, Olesen J, Chasman DI, Nyholt DR, Avbersek A, Baum L, Berkovic S, Bradfield J, Buono RJ, Catarino CB, Cossette P, De Jonghe P, Depondt C, Dlugos D, Ferraro TN, French J, Hjalgrim H, Jamnadas-Khoda J, Kälviäinen R, Kunz WS, Lerche H, Leu C, Lindhout D, Lo W, Lowenstein D, McCormack M, Møller RS, Molloy A, Ng PW, Oliver K, Privitera M, Radtke R, Ruppert AK, Sander T, Schachter S, Schankin C, Scheffer I, Schoch S, Sisodiya SM, Smith P, Sperling M, Striano P, Surges R, Thomas GN, Visscher F, Whelan CD, Zara F, Heinzen EL, Marson A, Becker F, Stroink H, Zimprich F, Gasser T, Gibbs R, Heutink P, Martinez M, Morris HR, Sharma M, Ryten M, Mok KY, Pulit S, Bevan S, Holliday E, Attia J, Battey T, Boncoraglio G, Thijs V, Chen WM, Mitchell B, Rothwell P, Sharma P, Sudlow C, Vicente A, Markus H, Kourkoulis C, Pera J, Raffeld M, Silliman S, Boraska Perica V, Thornton LM, Huckins LM, William Rayner N, Lewis CM, Gratacos M, Rybakowski F, Keski-Rahkonen A, Raevuori A, Hudson JI, Reichborn-Kjennerud T, Monteleone P, Karwautz A, Mannik K, Baker JH, O'Toole JK, Trace SE, Davis OSP, Helder SG, Ehrlich S, Herpertz-Dahlmann B, Danner UN, van Elburg AA, Clementi M, Forzan M, Docampo E, Lissowska J, Hauser J, Tortorella A, Maj M, Gonidakis F, Tziouvas K, Papezova H, Yilmaz Z, Wagner G, Cohen-Woods S, Herms S, Julià A, Rabionet R, Dick DM, Ripatti S, Andreassen OA, Espeseth T, Lundervold AJ, Steen VM, Pinto D, Scherer SW, Aschauer H, Schosser A, Alfredsson L, Padyukov L, Halmi KA, Mitchell J, Strober M, Bergen AW, Kaye W, Szatkiewicz JP, Cormand B, Ramos-Quiroga JA, Sánchez-Mora C, Ribasés M, Casas M, Hervas A, Arranz MJ, Haavik J, Zayats T, Johansson S, Williams N, Dempfle A, Rothenberger A, Kuntsi J, Oades RD, Banaschewski T, Franke B, Buitelaar JK, Arias Vasquez A, Doyle AE, Reif A, Lesch KP, Freitag C, Rivero O, Palmason H, Romanos M, Langley K, Rietschel M, Witt SH, Dalsgaard S, Børglum AD, Waldman I, Wilmot B, Molly N, Bau CHD, Crosbie J, Schachar R, Loo SK, McGough JJ, Grevet EH, Medland SE, Robinson E, Weiss LA, Bacchelli E, Bailey A, Bal V, Battaglia A, Betancur C, Bolton P, Cantor R, Celestino-Soper P, Dawson G, De Rubeis S, Duque F, Green A, Klauck SM, Leboyer M, Levitt P, Maestrini E, Mane S, De-Luca DM, Parr J, Regan R, Reichenberg A, Sandin S, Vorstman J, Wassink T, Wijsman E, Cook E, Santangelo S, Delorme R, Rogé B, Magalhaes T, Arking D, Schulze TG, Thompson RC, Strohmaier J, Matthews K, Melle I, Morris D, Blackwood D, McIntosh A, Bergen SE, Schalling M, Jamain S, Maaser A, Fischer SB, Reinbold CS, Fullerton JM, Guzman-Parra J, Mayoral F, Schofield PR, Cichon S, Mühleisen TW, Degenhardt F, Schumacher J, Bauer M, Mitchell PB, Gershon ES, Rice J, Potash JB, Zandi PP, Craddock N, Ferrier IN, Alda M, Rouleau GA, Turecki G, Ophoff R, Pato C, Anjorin A, Stahl E, Leber M, Czerski PM, Cruceanu C, Jones IR, Posthuma D, Andlauer TFM, Forstner AJ, Streit F, Baune BT, Air T, Sinnamon G, Wray NR, MacIntyre DJ, Porteous D, Homuth G, Rivera M, Grove J, Middeldorp CM, Hickie I, Pergadia M, Mehta D, Smit JH, Jansen R, de Geus E, Dunn E, Li QS, Nauck M, Schoevers RA, Beekman AT, Knowles JA, Viktorin A, Arnold P, Barr CL, Bedoya-Berrio G, Bienvenu OJ, Brentani H, Burton C, Camarena B, Cappi C, Cath D, Cavallini M, Cusi D, Darrow S, Denys D, Derks EM, Dietrich A, Fernandez T, Figee M, Freimer N, Gerber G, Grados M, Greenberg E, Hanna GL, Hartmann A, Hirschtritt ME, Hoekstra PJ, Huang A, Huyser C, Illmann C, Jenike M, Kuperman S, Leventhal B, Lochner C, Lyon GJ, Macciardi F, Madruga-Garrido M, Malaty IA, Maras A, McGrath L, Miguel EC, Mir P, Nestadt G, Nicolini H, Okun MS, Pakstis A, Paschou P, Piacentini J, Pittenger C, Plessen K, Ramensky V, Ramos EM, Reus V, Richter MA, Riddle MA, Robertson MM, Roessner V, Rosário M, Samuels JF, Sandor P, Stein DJ, Tsetsos F, Van Nieuwerburgh F, Weatherall S, Wendland JR, Wolanczyk T, Worbe Y, Zai G, Goes FS, McLaughlin N, Nestadt PS, Grabe HJ, Depienne C, Konkashbaev A, Lanzagorta N, Valencia-Duarte A, Bramon E, Buccola N, Cahn W, Cairns M, Chong SA, Cohen D, Crespo-Facorro B, Crowley J, Davidson M, DeLisi L, Dinan T, Donohoe G, Drapeau E, Duan J, Haan L, Hougaard D, Karachanak-Yankova S, Khrunin A, Klovins J, Kučinskas V, Lee Chee Keong J, Limborska S, Loughland C, Lönnqvist J, Maher B, Mattheisen M, McDonald C, Murphy KC, Nenadic I, van Os J, Pantelis C, Pato M, Petryshen T, Quested D, Roussos P, Sanders AR, Schall U, Schwab SG, Sim K, So HC, Stögmann E, Subramaniam M, Toncheva D, Waddington J, Walters J, Weiser M, Cheng W, Cloninger R, Curtis D, Gejman PV, Henskens F, Mattingsdal M, Oh SY, Scott R, Webb B, Breen G, Churchhouse C, Bulik CM, Daly M, Dichgans M, Faraone SV, Guerreiro R, Holmans P, Kendler KS, Koeleman B, Mathews CA, Price A, Scharf J, Sklar P, Williams J, Wood NW, Cotsapas C, Palotie A, Smoller JW, Sullivan P, Rosand J, Corvin A, Neale BM, Schott JM, Anney R, Elia J, Grigoroiu-Serbanescu M, Edenberg HJ, Murray R.

Science. 2018 Jun 22;360(6395). pii: eaap8757. doi: 10.1126/science.aap8757.

29.

Linking migraine frequency with family history of migraine.

Pelzer N, Louter MA, van Zwet EW, Nyholt DR, Ferrari MD, van den Maagdenberg AM, Haan J, Terwindt GM.

Cephalalgia. 2019 Feb;39(2):229-236. doi: 10.1177/0333102418783295. Epub 2018 Jun 17.

30.

Innovative Magnetic Resonance Imaging Markers of Hereditary Cerebral Amyloid Angiopathy at 7 Tesla.

Koemans EA, van Etten ES, van Opstal AM, Labadie G, Terwindt GM, Wermer MJH, Webb AG, Gurol EM, Greenberg SM, van Buchem MA, van der Grond J, van Rooden S.

Stroke. 2018 Jun;49(6):1518-1520. doi: 10.1161/STROKEAHA.117.020302. Epub 2018 Apr 25.

31.

Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling.

Noga MJ, Zielman R, van Dongen RM, Bos S, Harms A, Terwindt GM, van den Maagdenberg AMJM, Hankemeier T, Ferrari MD.

Metabolomics. 2018;14(4):44. doi: 10.1007/s11306-018-1333-0. Epub 2018 Mar 5.

32.

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment.

MaassenVanDenBrink A, Terwindt GM, van den Maagdenberg AMJM.

Genome Med. 2018 Feb 22;10(1):10. doi: 10.1186/s13073-018-0524-7.

33.

[Medication-overuse headache].

Pijpers JA, Wiendels NJ, Koppen H, Ferrari MD, Haan J, Terwindt GM.

Ned Tijdschr Geneeskd. 2018;162:D1749. Dutch.

PMID:
29350119
34.

Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation.

Pelzer N, Haan J, Stam AH, Vijfhuizen LS, Koelewijn SC, Smagge A, de Vries B, Ferrari MD, van den Maagdenberg AMJM, Terwindt GM.

Neurology. 2018 Feb 13;90(7):e575-e582. doi: 10.1212/WNL.0000000000004966. Epub 2018 Jan 17.

PMID:
29343472
35.

Circulating Endothelial Markers in Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.

Pelzer N, Bijkerk R, Reinders MEJ, van Zonneveld AJ, Ferrari MD, van den Maagdenberg AMJM, Eikenboom J, Terwindt GM.

Stroke. 2017 Dec;48(12):3301-3307. doi: 10.1161/STROKEAHA.117.018556. Epub 2017 Nov 7.

PMID:
29114091
36.

Primary headaches.

Onderwater GLJ, Van Dongen RM, Zielman R, Terwindt GM, Ferrari MD.

Handb Clin Neurol. 2017;146:267-284. doi: 10.1016/B978-0-12-804279-3.00016-2. Review.

PMID:
29110775
37.

Volumetric brain changes in migraineurs from the general population.

Palm-Meinders IH, Arkink EB, Koppen H, Amlal S, Terwindt GM, Launer LJ, van Buchem MA, Ferrari MD, Kruit MC.

Neurology. 2017 Nov 14;89(20):2066-2074. doi: 10.1212/WNL.0000000000004640. Epub 2017 Oct 11.

38.

Shared genetic risk between migraine and coronary artery disease: A genome-wide analysis of common variants.

Winsvold BS, Bettella F, Witoelar A, Anttila V, Gormley P, Kurth T, Terwindt GM, Freilinger TM, Frei O, Shadrin A, Wang Y, Dale AM, van den Maagdenberg AMJM, Chasman DI, Nyholt DR, Palotie A, Andreassen OA, Zwart JA; International Headache Genetics Consortium.

PLoS One. 2017 Sep 28;12(9):e0185663. doi: 10.1371/journal.pone.0185663. eCollection 2017.

39.

Chronotypes and circadian timing in migraine.

van Oosterhout W, van Someren E, Schoonman GG, Louter MA, Lammers GJ, Ferrari MD, Terwindt GM.

Cephalalgia. 2018 Apr;38(4):617-625. doi: 10.1177/0333102417698953. Epub 2017 Mar 20.

40.

Migraine and vascular disease biomarkers: A population-based case-control study.

Tietjen GE, Khubchandani J, Herial N, Palm-Meinders IH, Koppen H, Terwindt GM, van Buchem MA, Launer LJ, Ferrari MD, Kruit MC.

Cephalalgia. 2018 Mar;38(3):511-518. doi: 10.1177/0333102417698936. Epub 2017 Mar 15.

41.

Medication overuse headache: An ongoing debate.

Louter MA, Robbins MS, Terwindt GM.

Neurology. 2017 Sep 19;89(12):1206-1207. doi: 10.1212/WNL.0000000000004374. Epub 2017 Aug 18. No abstract available.

PMID:
28821689
42.

Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?

Hardy TA, Young S, Sy JS, Colley AF, Terwindt GM, Ferrari MD, Hayes MW, Hodgkinson S.

J Neurol Neurosurg Psychiatry. 2017 Aug 9. pii: jnnp-2017-316142. doi: 10.1136/jnnp-2017-316142. [Epub ahead of print] No abstract available.

PMID:
28794152
43.

Brain atrophy following hemiplegic migraine attacks.

Pelzer N, Hoogeveen ES, Ferrari MD, Poll-The BT, Kruit MC, Terwindt GM.

Cephalalgia. 2018 May;38(6):1199-1202. doi: 10.1177/0333102417723569. Epub 2017 Jul 27.

44.

Cortical glutamate in migraine.

Zielman R, Wijnen JP, Webb A, Onderwater GLJ, Ronen I, Ferrari MD, Kan HE, Terwindt GM, Kruit MC.

Brain. 2017 Jul 1;140(7):1859-1871. doi: 10.1093/brain/awx130.

PMID:
28633367
45.

Chronic headache: What's in a name?

Louter MA, Ward TN, Terwindt GM.

Neurology. 2017 Jul 18;89(3):224-225. doi: 10.1212/WNL.0000000000004124. Epub 2017 Jun 14. No abstract available.

PMID:
28615431
46.

Migraine and Cerebrovascular Atherosclerosis in Patients With Ischemic Stroke.

van Os HJA, Mulder IA, Broersen A, Algra A, van der Schaaf IC, Kappelle LJ, Velthuis BK, Terwindt GM, Schonewille WJ, Visser MC, Ferrari MD, van Walderveen MAA, Wermer MJH; DUST Investigators.

Stroke. 2017 Jul;48(7):1973-1975. doi: 10.1161/STROKEAHA.116.016133. Epub 2017 May 19.

PMID:
28526767
47.

Migraine prevalence in patients with unruptured intracranial aneurysms: A case-control study.

Witvoet EH, Pelzer N, Terwindt GM, Rinkel GJE, Vlak MHM, Algra A, Wermer MJH.

Brain Behav. 2017 Mar 30;7(5):e00662. doi: 10.1002/brb3.662. eCollection 2017 May.

48.

Detection of interferon alpha protein reveals differential levels and cellular sources in disease.

Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, McGlasson SL, Alyanakian MA, Bader-Meunier B, Barnerias C, Bellon N, Belot A, Bodemer C, Briggs TA, Desguerre I, Frémond ML, Hully M, van den Maagdenberg AMJM, Melki I, Meyts I, Musset L, Pelzer N, Quartier P, Terwindt GM, Wardlaw J, Wiseman S, Rieux-Laucat F, Rose Y, Neven B, Hertel C, Hayday A, Albert ML, Rozenberg F, Crow YJ, Duffy D.

J Exp Med. 2017 May 1;214(5):1547-1555. doi: 10.1084/jem.20161451. Epub 2017 Apr 18.

49.

Iron in deep brain nuclei in migraine? CAMERA follow-up MRI findings.

Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, van Buchem MA, Ferrari MD, Kruit MC.

Cephalalgia. 2017 Jul;37(8):795-800. doi: 10.1177/0333102416668654. Epub 2017 Apr 6.

50.

Allodynia in cluster headache.

Wilbrink LA, Louter MA, Teernstra OPM, van Zwet EW, Huygen FJPM, Haan J, Ferrari MD, Terwindt GM.

Pain. 2017 Jun;158(6):1113-1117. doi: 10.1097/j.pain.0000000000000891.

PMID:
28267062

Supplemental Content

Loading ...
Support Center